We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

National Cancer Institute Thai Cancer Anemia Survey

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01030159
Recruitment Status : Completed
First Posted : December 11, 2009
Last Update Posted : April 9, 2014
Information provided by (Responsible Party):
Janssen-Cilag Ltd.,Thailand

December 10, 2009
December 11, 2009
April 9, 2014
June 2006
May 2008   (Final data collection date for primary outcome measure)
Number of patients that have anemia during cancer therapy [ Time Frame: 6 months ]
Same as current
Complete list of historical versions of study NCT01030159 on ClinicalTrials.gov Archive Site
Characteristics of patients example treatment duration, type of chemotherapy used, grade of anemia [ Time Frame: 6 months ]
Same as current
Not Provided
Not Provided
National Cancer Institute Thai Cancer Anemia Survey
Anemia Survey in Cancer Patients Study
The purpose of this study is to create a large Thailand database documenting the severity of anemia and its management in the cancer population.
Thai Cancer Anemia Study (TCAS) is a prospective survey that will track anemia management in an adult cancer population. This survey is not intended to interfere with standard medical practices for handling anemia. Information on laboratory values including target and achieved hemaglobin (Hb) levels during chemotherapy cycles, use of blood transfusions, iron supplementation, and epoetin will be collected in addition to information on cancer status and treatment. Data on the level that triggers clinicians to decide on the need for anemia therapy will also be collected. Each patient included in the survey will be followed for six months. Observational Study - No investigational drug administered
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Anemic patients with cancer receiving chemotherapy
  • Anemia
  • Cancer
Other: Adult Cancer Patients
Tracking anemia management in Adult Cancer Patients
Intervention: Other: Adult Cancer Patients
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
May 2008
May 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with cancer

Exclusion Criteria:

Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Janssen-Cilag Ltd.,Thailand
Janssen-Cilag Ltd.,Thailand
Not Provided
Study Director: Janssen-Cilag Ltd Clinical Trial Janssen-Cilag Ltd.
Janssen-Cilag Ltd.,Thailand
April 2014